The use of anti-human T lymphocyte porcine immunoglobulin and cyclosporine A to treat patients with acquired severe aplastic anemia

Acta Haematologica

Volumn 124, Issue 4, 2010, Pages 245-250

  Bing, Han ^a   Siyi, Yan ^a   Wei, Zhang ^a   Jian, Li ^a   Minghui, Duan ^a   Li, Jiao ^a   Shujie, Wang ^a   Daobin, Zhou ^a   Nong, Zou ^a   Tienan, Zhu ^a   Ying, Xu ^a   Yongqiang, Zhao ^a   Ti, Shen ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Anti human T lymphocyte porcine immunoglobulin; Cyclosporine A; Severe aplastic anemia

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; T LYMPHOCYTE ANTIBODY; TESTOSTERONE UNDECANOATE;

ADOLESCENT; ADULT; ALLERGIC REACTION; ANAPHYLACTIC SHOCK; APLASTIC ANEMIA; ARTICLE; BLEEDING; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG TOLERANCE; DRUG TREATMENT FAILURE; FEMALE; FEVER; FOLLOW UP; HUMAN; LIVER FUNCTION; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; RASH; SERUM SICKNESS; SEVERE APLASTIC ANEMIA; SIDE EFFECT; SWINE; TREATMENT RESPONSE;

AGED; ANEMIA, APLASTIC; ANIMALS; CONFIDENCE INTERVALS; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SWINE; T-LYMPHOCYTES;

EID: 78449251007     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321790     Document Type: Article

References (24)

1. Brodsky RA, Jones RJ: Aplastic anemia. Lancet 2005; 365: 1647-1656.
2. Young NS, Maciejewski J: The pathophysiology of acquired aplastic anemia. N Engl J Med 1997; 336: 1365-1372.
3. British Committee for Standards in Haematology: Guidelines for the diagnosis and management of aplastic anaemia. 2009. AA-june10.pdf.
4. Montan E, Ibanez L, Vidal X, Ballar? E, Puig R, Garc? N, Laporte JR, the Catalan Group for the Study of Agranulocytosis and Aplastic Anemia: Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 2008; 93: 518-523.
5. Kaufman DW, Kelly JP, Levy M, Shapiro S: The Drug Etiology of Agranulocytosis and Aplastic Anemia. New York, Oxford University Press, 1991.
6. Mary JY, Baumelou E, Guiguet M, the French Cooperative Group for Epidemiological Study of Aplastic Anemia: Epidemiology of aplastic anemia in France: a prospective multicenter study. Blood 1990; 75: 1646-1653.
7. Cartwright RA, McKinney PA, Williams L, Miller JG, Evans DI, Bentley DP, Bhavnani M: Aplastic anaemia incidence in parts of the United Kingdom in 1985. Leuk Res 1988; 12: 459-463.
8. Clausen N, Kreuger A, Salmi T, Storm- Mathisen I, Hohannesson G: Severe aplastic anaemia in the Nordic countries: a population based study of incidence, presentation, course, and outcome. Arch Dis Child 1996; 74: 319-322.
9. Maluf EM, Pasquini R, Eluf JN, Kelly J, Kaufman DW: Aplastic anemia in Brazil: incidence and risk factors. Am J Hematol 2002; 71: 268-274.
10. Yang C, Zhang X: Incidence survey of aplastic anemia in China. Chin Med Sci J 1991; 6: 203-207.
11. Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, Young NS: The epidemiology of aplastic anemia in Thailand. Blood 2006; 107: 1299-1307.
12. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H, the German Aplastic Anemia Study Group: Antithymocyte globulin with or without cyclosporine A: 11-year follow- up of a randomized trial comparing treatments of aplastic anemia. Blood 2003; 101: 1236-1242.
13. Young NS, Bacigalupo A, Marsh JC: Aplastic anemia: pathophysiology and treatment. Biol Blood Marrow Transplant 2010; 16 (suppl 1):119-125.
14. Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A: Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood 2000; 95: 1931-1934.
15. Rosenfeid S, Follman D, Nunez O, Young NS: Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-time outcome. JAMA 2003; 289: 1130-1135.
16. Chang MH, Kim KH, Kim HS, Jun HJ, Kim DH, Jang JH, Kim K, Jung CW: Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia. Eur J Haematol 2010; 84: 154-159.
17. Zheng YZ, Chu YL, Shao ZH, Zhang YZ, Chen GB: Antilymphocyte globulin combining with cyclosporine A in the treatment of severe aplastic anemia. Zhonghua Xue Ye Xue Za Zhi 1999; 20: 175-177.
18. He GS, Shao ZH, Zhang YZ, Liu H, Li K, Song LY, Zheng YZ, Chen GB, He H, Zhao MF, Shi J, Zhang H, Chu YL, Qian LS, Yang TY, Yang CL: Sequential intensified immunosuppressive therapy combining with hematopoietic growth factors in the treatment of severe aplastic anemia. Zhonghua Xue Ye Xue Za Zhi 2001; 22: 177-180.
19. He GS, Shao ZH, Liu H, Zhang YZ, Chen GB, Li K, Song LY, He H, Zhao MF, Fu R, Shi J, Bai J, Zhang H, Chu YL, Yang TY, Yang CL: A long-term follow-up study of 50 patients with severe aplastic anemia who have survived more than 3 years after immunosuppressive therapy. Zhonghua Xue Ye Xue Za Zhi 2002; 23: 229-232.
20. Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A, Omine M, Mizoguchi H: Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood 2007; 110: 1756-1761.
21. Barcigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, Coser P, Iacopino P, van Lint MT, Gluckman E, the European Group for Blood and Marrow Transplantation (EBMT) Working Party on SAA: Antilymphocyte globulin, cyclosporine , and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study on the EBMT SAA Working Party. Blood 1995; 85: 1348-1353.
22. Locasciulli A, Arcese W, Locatelli F, Bona ED, Bacigalupo A, the Italian Aplastic Anaemia Study Group: Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Lancet 2001; 357: 43-44.
23. Scheinberg P, Wu CO, Nunez O, Young NS: Predicting response to mmunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 2009; 144: 206-216.
24. Ahn MJ, Choi JH, Lee YY, Choi IY, Kim IS, Yoon SS, Park SY, Kim BK, Suh C, Son HJ, Jung CW, Lee JH, Sung JM, Im SA, Oh D, Jung SY, Yoon HJ, Cho KS, Lee JA, Yuh YJ, Kim SR, Ki M: Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial. Int J Hematol 2003; 78: 133-138.